Abstract
Antimicrobial susceptibility testing is an important and one of the most time-consuming and expensive procedures in microbiological laboratory. Use of appropriate panel of antibiotics along with correct identification of isolated pathogen make it possible to assume resistance mechanisms in the tested isolate and predict its susceptibility (resistance) to similar (by structure and/or mechanism of action) antimicrobial agents. This review describes principles of antibiotic choice for in vitro susceptibility testing as well as rules of testing results interpretation. Adherence to these principles and rules provides as many information as possible for administration of effective antibacterial therapy.
-
1.
Courvalin P., Interpretative reading, In: Courvalin P., Leclercq R., Rice L.B., editors. Antibioticogram. Portland, Oregon, USA: ESKA PUBLISHING, ASM PRESS; 2010. 47-54. A.P.
-
2.
Методические указания МУК 4.2.1890-04 «Определение чувствительности микроорганизмов к антибактериальным препаратам». 2004.
-
3.
Livermore D.M. Winstanley.T.G., Shannon K.P. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemotherapy 2001; 48(Suppl. S1):87-120.
-
4.
Courvalin. P. Interpretative reading of in vitro antibiotic susceptibility tests (the antibiogramme). Clin Microbiol Infect 1996; 2(Suppl 1):S26-S34.
-
5.
Leclercq R., Canton R., Brown D. F. J., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013; 19(2):141-60.
-
6.
Canton R., Akova M., Carmeli Y., Giske C.G., Glupczynski Y., Gniadkowski M., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect, 2012; 18:413-31.
-
7.
Skleenova E., Sukhorukova M., Timokhova A., Martinovich A., Savochkina J., Edelstein M., Kozlov R. Sharp Increase in Carbapenem-Non-Susceptibility and Carbapenemase Production Rates in Nosocomial Gram-Negative Bacteria in Russia over the Last Decade. Accepted at 53rd ICAAC 2013 2013; Control/Tracking Number: 2013-A-1789-ASM-ICAAC.
-
8.
Сухорукова М.В. Тимохова А.В., Эйдельштейн М.В., Козлов Р.С. Чувствительность к антибиотикам штаммов бактерий, входящих в состав пробиотика «Линекс». Клин микробиол антимикроб химиотер 2012; 14(3):245-51.
-
9.
CLSI, Performance Standards for Antimicrobial Susceptibility testing; Twenty-Third Informational Supplemeny. CLSI document M100-S23. Wayne, PA: Clinical nad Laboratory Standards Institute; 2013.
-
10.
http://www.ecdc.europa.eu/en/activities/diseaseprogrammes/ARHAI/Pages/public_consultation_clinical_microbiology_infection_article.aspx.
-
11.
Schreckenberger P.C., Binnicker M.J. Optimizing antimicrobial susceptibility test reporting. J Clin Microbiol 2011; 49(9) (Suppl):S15-S19.